Cordant Inc’s Checkpoint Therapeutics CKPT Stock Holding History

Cordant Inc’s Portfolio CKPT Stock Details CKPT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-1,550	Closed	-$6.26K	–	73
2025 Q1	$6.26K	Buy	+1,550	New	+$5.17K	﹤0.01%	73
2022 Q2	–	Sell	-1,082	Closed	-$19K	–	290
2022 Q1	$19K	Hold	1,082	–	–	0.01%	81
2021 Q4	$34K	Hold	1,082	–	–	0.02%	48
2021 Q3	$36K	Buy	+1,082	New	+$32K	0.02%	70

Cordant Inc's CKPT Position: Q2 2025 in Review

Cordant Inc sold out of Checkpoint Therapeutics (CKPT) in Q2 2025, closing a stake of 1,550 shares — an estimated $6.26K sold.

Cordant Inc first reported a position in CKPT in Q3 2021 and held it in 4 quarters. The position peaked at $36K in Q3 2021. 0 funds tracked by Wall St. Rank hold CKPT as of Q2 2025.

Cordant Inc reported no remaining Checkpoint Therapeutics position as of Q2 2025 after selling out during the quarter.
Cordant Inc sold 1,550 Checkpoint Therapeutics shares in Q2 2025, an estimated $6.26K.
Cordant Inc first reported a position in Checkpoint Therapeutics in Q3 2021 and held it in 4 quarters.
Cordant Inc's Checkpoint Therapeutics position peaked at $36K in Q3 2021.
0 funds tracked by Wall St. Rank held Checkpoint Therapeutics as of Q2 2025.

Based on Cordant Inc's 13F filing for Q2 2025, filed 15 Jul 2025.